{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:08:00Z","timestamp":1788368880261,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2501200"],"award-info":[{"award-number":["2021YFC2501200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2501205"],"award-info":[{"award-number":["2021YFC2501205"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201410"],"award-info":[{"award-number":["82201410"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201409"],"award-info":[{"award-number":["82201409"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.parkreldis.2026.108323","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:33:56Z","timestamp":1776285236000},"page":"108323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Serum metabolic markers for \u03b1-synucleinopathies conversion in isolated REM sleep behavior disorder: a prospective cohort study"],"prefix":"10.1016","volume":"147","author":[{"given":"Yajie","family":"Zang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8526-4440","authenticated-orcid":false,"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6570-1527","authenticated-orcid":false,"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1460-6748","authenticated-orcid":false,"given":"Chao","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feilong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1135-510X","authenticated-orcid":false,"given":"Zhiguang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanning","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piu","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7690-9013","authenticated-orcid":false,"given":"Wei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.parkreldis.2026.108323_bib1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3233\/JAD-220432","article-title":"Serum uric acid levels in neurodegenerative disorders: a cross-sectional study","volume":"90","author":"Aerqin","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.parkreldis.2026.108323_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.clineuro.2018.03.023","article-title":"Association between serum uric acid level and multiple system atrophy: a meta-analysis","volume":"169","author":"Zhang","year":"2018","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"11","key":"10.1016\/j.parkreldis.2026.108323_bib3","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/mds.29209","article-title":"Jinnah HA uric acid in Parkinson's disease: what is the connection?","volume":"37","author":"Seifar","year":"2022","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2026.108323_bib4","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/mds.27413","article-title":"Higher serum cholesterol and decreased Parkinson's disease risk: a statin\u2010free cohort study","volume":"33","author":"Rozani","year":"2018","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.parkreldis.2026.108323_bib5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/CIRCRESAHA.119.314929","article-title":"Lipids, apolipoproteins, and the risk of parkinson disease","volume":"125","author":"Fang","year":"2019","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108323_bib6","article-title":"Uric acid and alterations of purine recycling disorders in Parkinson's disease: a cross-sectional study","volume":"10","author":"Shima","year":"2024","journal-title":"npj Parkinson's Dis."},{"issue":"2","key":"10.1016\/j.parkreldis.2026.108323_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3233\/JAD-171042","article-title":"Homocysteine and dementia: an international consensus statement","volume":"62","author":"Smith","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108323_bib8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00415-022-11361-y","article-title":"Homocysteine levels, genetic background, and cognitive impairment in Parkinson's disease","volume":"270","author":"Peri\u00f1\u00e1n","year":"2022","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108323_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14376","article-title":"Homocysteine, neurodegenerative biomarkers, and APOE \u03b54 in neurodegenerative diseases","volume":"21","author":"Lin","year":"2024","journal-title":"Alzheimer's Dement."},{"issue":"4","key":"10.1016\/j.parkreldis.2026.108323_bib10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mds.26152","article-title":"Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study","volume":"30","author":"Huang","year":"2015","journal-title":"Mov. Disord. : Official Journal of the Movement Disorder Society"},{"issue":"3","key":"10.1016\/j.parkreldis.2026.108323_bib11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/mds.21290","article-title":"Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease","volume":"22","author":"Huang","year":"2007","journal-title":"Mov. Disord. : Official Journal of the Movement Disorder Society"},{"issue":"15","key":"10.1016\/j.parkreldis.2026.108323_bib12","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1001\/jama.300.15.1774","article-title":"High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial","volume":"300","author":"Aisen","year":"2008","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.parkreldis.2026.108323_bib13","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1001\/jama.2021.10207","article-title":"Effect of urate-elevating inosine on early parkinson disease progression: the SURE-PD3 randomized clinical trial","volume":"326","author":"Schwarzschild","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108323_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/jama.2021.21008","article-title":"Effect of urate-elevating inosine on progression of early parkinson disease","volume":"327","author":"Frucht","year":"2022","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.parkreldis.2026.108323_bib15","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.sleep.2012.10.009","article-title":"Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series","volume":"14","author":"Schenck","year":"2013","journal-title":"Sleep Med."},{"issue":"8","key":"10.1016\/j.parkreldis.2026.108323_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsx071","article-title":"Prodromal parkinsonism and neurodegenerative risk stratification in REM sleep behavior disorder","volume":"40","author":"Barber","year":"2017","journal-title":"Sleep"},{"issue":"8","key":"10.1016\/j.parkreldis.2026.108323_bib17","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/mds.25441","article-title":"Plasma urate in REM sleep behavior disorder","volume":"28","author":"Mart\u00edn","year":"2013","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.parkreldis.2026.108323_bib18","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1007\/s00702-018-1935-8","article-title":"Effect of serum uric acid on cognition in patients with idiopathic REM sleep behavior disorder","volume":"125","author":"Li","year":"2018","journal-title":"J. Neural Transm."},{"issue":"12","key":"10.1016\/j.parkreldis.2026.108323_bib19","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/acn3.50929","article-title":"Plasma urate concentrations and possible REM sleep behavior disorder","volume":"6","author":"Shen","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2026.108323_bib20","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/mds.28421","article-title":"Hypomethylation of SNCA in idiopathic REM sleep behavior disorder associated with phenoconversion","volume":"36","author":"Li","year":"2021","journal-title":"Mov. Disord. : Official Journal of the Movement Disorder Society"},{"issue":"12","key":"10.1016\/j.parkreldis.2026.108323_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12121728","article-title":"Fatigue in patients with Idiopathic\/Isolated REM sleep behavior disorder","volume":"12","author":"Zang","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.parkreldis.2026.108323_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.parkreldis.2020.07.017","article-title":"Plasma immune markers in an idiopathic REM sleep behavior disorder cohort","volume":"78","author":"Zhang","year":"2020","journal-title":"Parkinsonism Relat. Disorders"},{"key":"10.1016\/j.parkreldis.2026.108323_bib23","series-title":"Nihon Rinsho Japanese Journal of Clinical Medicine","first-page":"916","volume":"vol. 73","author":"Ito","year":"2015"},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108323_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.sleep.2009.06.008","article-title":"Validation of a new REM sleep behavior disorder questionnaire (RBDQ-HK)","volume":"11","author":"Li","year":"2010","journal-title":"Sleep Med."},{"issue":"6","key":"10.1016\/j.parkreldis.2026.108323_bib25","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.29005","article-title":"The movement disorder society criteria for the diagnosis of multiple system atrophy","volume":"37","author":"Wenning","year":"2022","journal-title":"Mov. Disord. : Official Journal of the Movement Disorder Society"},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108323_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with lewy bodies: fourth consensus report of the DLB consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.parkreldis.2026.108323_bib27","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord. : Official Journal of the Movement Disorder Society"},{"issue":"5","key":"10.1016\/j.parkreldis.2026.108323_bib28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/mds.26535","article-title":"Relationship between uric acid levels and progressive supranuclear palsy","volume":"31","author":"Brody","year":"2016","journal-title":"Mov. Disord."},{"issue":"17","key":"10.1016\/j.parkreldis.2026.108323_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713067","article-title":"Glutathione-mediated neuroprotective effect of purine derivatives","volume":"24","author":"Matsumura","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.parkreldis.2026.108323_bib30","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3233\/JPD-201988","article-title":"Serum uric acid levels and non-motor symptoms in parkinson's disease","volume":"10","author":"van Wamelen","year":"2020","journal-title":"J. Parkinsons Dis."},{"issue":"7","key":"10.1016\/j.parkreldis.2026.108323_bib31","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1007\/s10072-025-08112-y","article-title":"Di Lazzaro V The role of uric acid in Parkinson's disease: a UK brain bank pathology-validated case\u2013control study","volume":"46","author":"di Biase","year":"2025","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108323_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JAD-2011-110587","article-title":"Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and Amyloid-\u03b2 pathway","volume":"27","author":"Maetzler","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"9","key":"10.1016\/j.parkreldis.2026.108323_bib33","article-title":"Relationships between serum lipid, uric acid levels and mild cognitive impairment in Parkinson's disease and multiple system atrophy","volume":"23","author":"Shi","year":"2024","journal-title":"J. Integr. Neurosci."},{"issue":"2","key":"10.1016\/j.parkreldis.2026.108323_bib34","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1523\/JNEUROSCI.18-02-00687.1998","article-title":"Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction","volume":"18","author":"Keller","year":"1998","journal-title":"J. Neurosci. : the Official Journal of the Society For Neuroscience"},{"issue":"7","key":"10.1016\/j.parkreldis.2026.108323_bib35","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer's disease","volume":"346","author":"Seshadri","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.parkreldis.2026.108323_bib36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3233\/JAD-220410","article-title":"Serum homocysteine, vitamin B12, folate, and their association with mild cognitive impairment and subtypes of dementia","volume":"90","author":"Song","year":"2022","journal-title":"J. Alzheimers Dis."},{"issue":"23","key":"10.1016\/j.parkreldis.2026.108323_bib37","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1212\/WNL.0000000000001050","article-title":"Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT","volume":"83","author":"van der Zwaluw","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2026.108323_bib38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neubiorev.2016.08.014","article-title":"Ayesa-Arriola R Homocysteine and cognition: a systematic review of 111 studies","volume":"69","author":"Seti\u00e9n-Suero","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"10","key":"10.1016\/j.parkreldis.2026.108323_bib39","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","article-title":"Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications","volume":"14","author":"Biessels","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"11","key":"10.1016\/j.parkreldis.2026.108323_bib40","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1002\/jcp.29682","article-title":"Glucose, glycolysis, and neurodegenerative diseases","volume":"235","author":"Tang","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.parkreldis.2026.108323_bib41","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/mds.27006","article-title":"Statins may facilitate Parkinson's disease: insight gained from a large, national claims database","volume":"32","author":"Liu","year":"2017","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.parkreldis.2026.108323_bib42","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/01.STR.0000217384.03237.9c","article-title":"Girotti F reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study","volume":"37","author":"Scigliano","year":"2006","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.parkreldis.2026.108323_bib43","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"14","author":"Fasano","year":"2015","journal-title":"Lancet Neurol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026001501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026001501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:43:24Z","timestamp":1780580604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802026001501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":43,"alternative-id":["S1353802026001501"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108323","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum metabolic markers for \u03b1-synucleinopathies conversion in isolated REM sleep behavior disorder: a prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108323"}}